Clinical Trials in Houston

Showing 8581-8600 of 13,620 trials

PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD

NCT03172481

This is a randomized, double-blind, parallel group, placebo-controlled, dose optimized, phase 3 study to evaluate the safety and efficacy of PRC-063 in the treatment of ADHD in pediatric subjects between 6 to 12 years of age.

ADHD

Purdue Pharma, Canada156 participantsStarted May 2017

Newport Beach, California, United States • Bradenton, Florida, United States • Maitland, Florida, United States +3 more locations

COMPLETEDNA< 1 mile

Evaluation of the Archimedes™ System for Transparenchymal Nodule Access 2

NCT02867371

The Archimedes System is an image-guided navigation system used to access tissue samples in the lungs. This study is being conducted to confirm the performance of the Archimedes System in patients who are scheduled for standard bronchoscopy to diagnose highly suspicious lung cancer or metastatic disease. Navigation to and sampling of the patient's lung cancer tumor is conducted.

Lung Cancer

Broncus Medical Inc166 participantsStarted Aug 2016

Boston, Massachusetts, United States • Durham, North Carolina, United States • Tulsa, Oklahoma, United States +7 more locations

PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD

Evaluation of the Archimedes™ System for Transparenchymal Nodule Access 2

Find Trials by Condition in Houston

Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission

SPRINT - Randomized Trial of Tibial Fracture Fixation

Evaluation of AP-002 in Patients With Solid Tumors

A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL)

Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia

World-wide Randomized Antibiotic Envelope Infection Prevention Trial

Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP)

Study in Subjects With Moderate Atopic Dermatitis

Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

A Phase I Study to Assess the Safety, Pharmacokinetics, and Potential Effects of Amrubicin on the QT/QTc Interval in Cancer Patients With Advanced Solid Tumors.

A Safety and Pharmacokinetic Study of TAK-228 in Combination With TAK-117 in Adult Participants With Advanced Nonhematologic Malignancies

Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis

A Study to Assess Menstrual Cramp Pain Associated With Primary Dysmenorrhea

A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease

Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects

A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care

Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma

A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066